<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Once eligibility and interest were determined, participants were invited to complete the 45–75-min in-depth interview. The interview followed a semi-structured format. After collecting demographic information, we asked participants about their experiences with the KCHD SSP when it was operational, their access to sterile syringes and overdose prevention resources after the SSP suspension, syringe sharing, perceptions of HIV risk, and current challenges to HIV prevention. Participants were compensated $40 for their time. Interviews were audio-recorded with participants’ permission and transcribed 
 <italic>verbatim</italic>. All study procedures were approved by the Johns Hopkins School of Public Health Institutional Review Board.
</p>
